Cargando…

Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies

Detalles Bibliográficos
Autores principales:	Gorman, J, McLellan, J, Yang, Y, Zhou, T, Zhu, J, Bangaru, S, Bayless, N, Alff, P, Marshall, CP, Kwong, PD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442054/ http://dx.doi.org/10.1186/1742-4690-9-S2-P84

Ejemplares similares

V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site
por: McLellan, JS, et al.
Publicado: (2012)

2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies
por: Zhang, H, et al.
Publicado: (2012)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein
por: Hicar, Mark D., et al.
Publicado: (2016)

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies
por: Doria-Rose, NA, et al.
Publicado: (2012)

Myomedin replicas of gp120 V3 loop glycan epitopes recognized by PGT121 and PGT126 antibodies as non-cognate antigens for stimulation of HIV-1 broadly neutralizing antibodies
por: Daniel Lišková, Veronika, et al.
Publicado: (2022)

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies
por: Fuchs, JD, et al.
Publicado: (2012)

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
por: Gorman, Jason, et al.
Publicado: (2015)

ESHRE PGT Consortium good practice recommendations for the organisation of PGT
por: Carvalho, Filipa, et al.
Publicado: (2020)

ESHRE PGT Consortium data collection XXI: PGT analyses in 2018(†)
por: Spinella, F, et al.
Publicado: (2023)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

PGT or ICSI? The impression of NGS-based PGT outcomes in nonmosaic Klinefelter syndrome
por: Tong, Jing, et al.
Publicado: (2021)

Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2
por: Rolland, Morgane, et al.
Publicado: (2012)

Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
por: Julien, Jean-Philippe, et al.
Publicado: (2013)

Optimized NGS Approach for Detection of Aneuploidies and Mosaicism in PGT-A and Imbalances in PGT-SR
por: García-Pascual, Carmen M., et al.
Publicado: (2020)

Commentary on “PGT or ICSI? The impression of NGS-based PGT outcomes in nonmosaic Klinefelter syndrome”
por: Greco, Ermanno, et al.
Publicado: (2021)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response
por: Heydarchi, Behnaz, et al.
Publicado: (2016)

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
por: Mason, Rosemarie D., et al.
Publicado: (2016)

Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality
por: Goike, Jule, et al.
Publicado: (2021)

ESHRE PGT Consortium data collection XIX–XX: PGT analyses from 2016 to 2017(†)
por: van Montfoort, A, et al.
Publicado: (2021)

Somatic Populations of PGT135–137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics
por: Zhu, Jiang, et al.
Publicado: (2012)

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
por: Mason, Rosemarie D., et al.
Publicado: (2016)

Functional bottlenecks for generation of HIV-1 intersubtype Env recombinants
por: Bagaya, Bernard S., et al.
Publicado: (2015)

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
por: Krumm, Stefanie A., et al.
Publicado: (2016)

ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT
por: Kokkali, Georgia, et al.
Publicado: (2020)

Feline immunodeficiency virus (FIV) env recombinants are common in natural infections
por: Bęczkowski, Paweł M, et al.
Publicado: (2014)

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
por: Yasmeen, Anila, et al.
Publicado: (2014)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure
por: Parsons, Matthew S., et al.
Publicado: (2021)

Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates
por: Theis, JF, et al.
Publicado: (2012)

An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies
por: Boliar, Saikat, et al.
Publicado: (2015)

The Quaternary Structure of the Recombinant Bovine Odorant-Binding Protein Is Modulated by Chemical Denaturants
por: Stepanenko, Olga V., et al.
Publicado: (2014)

HIV-1 CD4-binding site germline antibody–Env structures inform vaccine design
por: Dam, Kim-Marie A., et al.
Publicado: (2022)

Structural Basis for Binding of Neutralizing Antibodies to Clostridioides difficile Binary Toxin
por: Goldsmith, Jory A., et al.
Publicado: (2023)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
por: Wu, Nicholas C., et al.
Publicado: (2020)

E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost
por: Hutnick, NA, et al.
Publicado: (2012)

Envés
por: Amara, Luigi, 1971-
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ltss83aeqie5s1gb7vl9l4hlrh